It also offers less frequent dosing, given as a subcutaneous injection once every ... and concurrent haemoglobin increase compared to epoetin alfa," he added. BMS is also testing Reblozyl in ...

Welcome to our quarterly update relating to biologics and biosimilars, including post-grant and patent litigation challenges to blockbuster biologics. Since the enactment of the Biologics Price ...